Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Donanemab puts brakes on Alzheimer’s disease progression

Donanemab puts brakes on Alzheimer’s disease progression

26 Jul 2023

In the treatment of individuals with early symptomatic Alzheimer's disease and amyloid and tau pathology, the immunoglobulin G1 monoclonal antibody donanemab helps slow clinical progression, according to the results of the phase III TRAILBLAZER-ALZ 2 study.

Donanemab puts brakes on Alzheimer’s disease progression

26 Jul 2023
Rotavirus infection linked to gastroenteritis, neurological complications in children

Rotavirus infection linked to gastroenteritis, neurological complications in children

20 Jul 2023
Theophylline shows promise in SCI-induced bradycardia

Theophylline shows promise in SCI-induced bradycardia

18 Jul 2023